WAG
GILD icon

Wiser Advisor Group’s Gilead Sciences GILD Stock Holding History

Wiser Advisor Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.2K Buy
+239
New +$31.5K 0.03% 108
2024
Q3 		– Sell
-69
Closed -$4.69K – 272
2024
Q2 		$4.69K Buy
69
+2
+3% +$133 0.01% 221
2024
Q1 		$4.95K Hold
67
– – 0.01% 222
2023
Q4 		$5.42K Buy
+67
New +$5.21K 0.01% 217

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wiser Advisor Group's GILD Position: Q2 2026 in Review

Wiser Advisor Group opened a new position in Gilead Sciences (GILD) in Q2 2026: 239 shares worth $30.2K. The stake represents 0.03% of the portfolio and ranks #108 among its holdings. This is a return to the name: Wiser Advisor Group previously reported a position in GILD as recently as Q2 2024.

Wiser Advisor Group first reported a position in GILD in Q4 2023 and has held it in 4 quarters since. 2,277 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wiser Advisor Group held 239 shares of Gilead Sciences worth $30.2K as of Q2 2026.
  • Gilead Sciences was a new Wiser Advisor Group position in Q2 2026.
  • Gilead Sciences made up 0.03% of Wiser Advisor Group's portfolio in Q2 2026, its #108 holding.
  • Wiser Advisor Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 4 quarters since.
  • 2,277 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wiser Advisor Group's 13F filing for Q2 2026, filed 17 Aug 2026.